Homburger advised 21Shares on the completion of a merger by absorption, pursuant to which FalconX, acquired 21Shares’ ultimate parent company. The transaction was completed in November 2025. Following the merger, 21Shares continues to operate as an independent company within the FalconX group, retaining its existing management team and brand. The Homburger team Margrit Marti (corporate/M&A, […]
SIX-listed Santhera Pharmaceuticals has signed an exclusive licensing agreement with biopharma company Nxera Pharma for the development, manufacturing and commercialisation across Japan, South Korea, Australia and New Zealand of Agamree, a prescription medicine used to
Bär & Karrer advised Allurity, a European group of cybersecurity service providers, on its acquisition of Swiss operational technology security specialist Monti Stampa Furrer & Partners Group (MSF Partners). The firm worked on all
MME advised Kraken, as the US-based cryptocurrency exchange acquired Swiss tokenized assets specialist Backed Finance, the developer of blockchain platform xStocks. The MME team Partners Alex Enzler (corporate/M&A, pictured left) and Ronald
Niederer Kraft Frey (NKF) advised Georg Fischer (GF), as the SIX-listed Swiss industrial company completed the divestment of its iron foundry in Leipzig (Germany) to Linamar Corp, a globally active manufacturer of advanced mobility and
Bär & Karrer advised EPA-listed Synergie, as the company agreed to acquire a majority stake in House of Flexwork, a Swiss staffing agency operating under the brands Induserv, Hardworker and Payroll House. The Bä
Vischer advised Relief, now MindMaze Therapeutics Holding, in connection with its acquisition of all shares in NeuroX Group, against issuance of new MMTX shares to complete their business combination by way of reverse merger.
MLL Legal advised SIX-listed Datwyler Group on the acquisition of a 51% stake in Capsul’In, a Luxembourg-based provider of aluminium coffee capsule solutions. Closing of the transaction is expected in the first quarter of 2026. The
Advestra advised the financing sources, undisclosed, in connection with the acquisition of u-blox by the ZI Zenith funds, an indirect subsidiary of Advent International. The deal took place by way of a public tender offer.
Homburger advised Windward Bio Group — a Swiss-based biotechnology specialist in advanced immunological diseases — in connection with a licensing agreement between the company’s affiliate, LE2025 Therapeutics, and Qyuns Therapeutics Co. for the development
